Medication info
Olmesartan Medoxomil Tablet 40mg (Olmesartan Medoxomil)

Olmesartan Medoxomil Tablet 40mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›40mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201100982 · Approved 2011.02.25 · Insurance code 645404090

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, the dose may be increased to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The antihypertensive effect occurs within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended that treatment be initiated at a low dose while their condition is closely monitored. <Elderly patients> No dosage adjustment is necessary when administering this drug to patients aged 65 years or older. No overall differences in efficacy or safety have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. As there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
Child dose
<Pediatric patients> Safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used to treat essential hypertension. It helps to effectively control blood pressure, reduce the risk of cardiovascular complications, and improve overall health.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, the dose may be increased to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The antihypertensive effect occurs within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended that treatment be initiated at a low dose while their condition is closely monitored. <Elderly patients> No dosage adjustment is necessary when administering this drug to patients aged 65 years or older. No overall differences in efficacy or safety have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. As there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.

Child dose

<Pediatric patients> Safety and efficacy in pediatric patients have not been established.

Precautions

This medicine can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. People who are allergic to this medicine or its ingredients, pregnant or nursing women, patients undergoing renal dialysis, those with severe liver impairment, biliary obstruction, and lactose intolerance should not use this medication. Patients with low blood volume or salt may experience hypotension upon initial use; thus, their condition should be closely monitored, and appropriate treatment should be implemented if hypotension occurs. Patients with impaired kidney function or those who have undergone kidney transplantation should regularly check kidney function and serum potassium levels through blood tests, and use of this drug is not recommended in severe renal impairment. Patients with renal artery stenosis, those at risk for hyperkalemia, and certain heart disease patients need to take extra caution when taking this medication. This drug can cause dizziness, so care should be taken when driving or operating dangerous machinery. During treatment, attention should be paid to avoid combinations with potassium-sparing diuretics or potassium supplements, certain analgesics, lithium, etc., and blood pressure, kidney function, and electrolyte levels should be monitored regularly. It should be avoided during pregnancy to prevent serious fetal anomalies, and in nursing mothers, the decision to use this drug should be made cautiously. The safety of this drug in children has not been established, and for the elderly, adjustments in dosage and monitoring are necessary due to the potential for increased drug levels in the body. In case of overdose, symptoms such as hypotension or palpitations may occur, so seek immediate medical attention for appropriate treatment. This drug is known to have a low risk of carcinogenicity or genotoxicity even with long-term use; however, if any abnormal symptoms occur during use, consultation with a professional should be sought immediately.

Side effects

  • Dizziness
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
Show 27 more
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • angioedema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute kidney failure
  • increased serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • headache
  • hypertension
  • epistaxis
  • upper respiratory infection
  • asthma
  • cough

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air or moisture, and it is recommended to keep it at room temperature between 1 degree and 25 degrees Celsius. Proper storage in suitable temperature and container can maintain the effectiveness and safety of the drug.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.